SCHEMBL3300356

SCHEMBL3300356

CCCCOc1cccc([SiH](O[SiH](c2cccc(OCCCC)c2C(C)(C)C)c2cccc(OCCCC)c2C(C)(C)C)c2cccc(OCCCC)c2C(C)(C)C)c1C(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
MCHR1 Q99705 3/20 0.38
TLR8 Q9NR97 1/20 0.35
HTR1B P28222 2/20 0.35
CYP19A1 P11511 1/20 0.35
HIF1A Q16665 1/20 0.35
CSNK1A1 P48729 1/20 0.34
CSNK1D P48730 1/20 0.34
PRKCD Q05655 1/20 0.34
PAK1 Q13153 1/20 0.34
CAMK2B Q13554 1/20 0.34
CAMK2G Q13555 1/20 0.34
CAMK2D Q13557 1/20 0.34
TAOK1 Q7L7X3 1/20 0.34
CNR2 P34972 1/20 0.34
KMT2A Q03164 2/20 0.33
HTR1D P28221 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3296985 0.86 GRK6 (0.40) CYP1A2CYP2C19KMT2AMEN1LMNA
SCHEMBL3296160 0.80 CYP1A2 (0.55) CYP1A2CYP2C9CYP2C19MCHR1TLR8
SCHEMBL3297503 0.80 CYP1A2 (0.46) CYP1A2CYP2C9CYP2C19MCHR1TLR8
SCHEMBL3294491 0.80 CYP1A2 (0.46) CYP1A2CYP2C9CYP2C19MCHR1TLR8
SCHEMBL3297921 0.78 CYP1A2 (0.45) CYP1A2CYP2C9CYP2C19MCHR1TLR8
SCHEMBL3297557 0.77 CA1 (0.38) KMT2AHTR1DMEN1LMNACYP3A4
SCHEMBL3297597 0.76 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19MCHR1TLR8
SCHEMBL3296752 0.76 ALDH1A1 (0.39) CYP1A2CYP2C9CYP2C19CYP19A1LTA4H
SCHEMBL3297756 0.75 CYP1A2 (0.52) CYP1A2CYP2C9CYP2C19MCHR1TLR8
SCHEMBL3298753 0.74 KDM4E (0.44) CYP1A2CYP2C9CYP2C19TLR8NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741393-B2 Organic silicon-based compound and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 US disclosed
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same ARSA, OR10J3, HDAC10 CYP1A2 945/4885CYP2C9 1864/4885CYP2C19 1527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.